Cells
SMOC reserves over 100 commonly used tumor cell lines, mostly derived from the ATCC and the Chinese Academy of Sciences Collection Committee cell bank. These cell lines can be used to offer technical services such as cell line knock-in/knock-out, cell proliferation/apoptosis, and cell migration/invasion.
Animal Model (These include, but are not limited to, the following data.)
Strain State (Con：Construction; Expr：Validation of target gene expression; TC：Validation of tumorigenic capacity; Parma：Validation of pharmacodynamic assays.)
|
Cell Line
|
Cancer Type
|
Category
|
Organism
|
Animal Model
|
Strain State
|
|||
|---|---|---|---|---|---|---|---|---|
|
Con
|
Expr
|
TC
|
Parma
|
|||||
| HEL 92.1.7-Luc | Leukemia | Reporter-labeled | Homo sapiens | M-NSG |
|
|||
| Hela | Cervical | Wild-type | Homo sapiens | M-NSG |
|
|||
| Hela-Luc | Cervical | Reporter-labeled | Homo sapiens |
|
||||
| Hep 3B2.1-7 [Hep 3B] | Liver | Wild-type | Homo sapiens | M-NSG |
|
|||
| Hep-2 | Pharyngeal | Wild-type | Homo sapiens |
|
||||
| Hep2-Luc | Pharyngeal | Reporter-labeled | Homo sapiens |
|
||||
| Hep3B-Luc | Liver | Reporter-labeled | Homo sapiens | M-NSG |
|
|||
| Hepa 1-6 | Liver | Wild-type | Mus musculus | C57BL/6 |
|
|||
| Hepa 1-6-hCD47 | Colon | Humanized Drug Targets | Mus musculus |
|
||||
| Hepa1-6-hCD47 | Liver | Humanized Drug Targets | Mus musculus |
|
||||
| Hepa1-6-hMSLN | Liver | Humanized Drug Targets | Mus musculus |
|
||||
| Hepa1-6-hPD-L1 | Liver | Humanized Drug Targets | Mus musculus |
|
||||
| Hepa1-6-Luc | Leukemia | Reporter-labeled | Homo sapiens |
|
||||
| HEPG2 | Liver | Wild-type | Homo sapiens | M-NSG |
|
|||
| HepG2-Luc | Liver | Reporter-labeled | Homo sapiens |
|
||||
| HFL1 | Lung | Wild-type | Homo sapiens |
|
||||
| HGC-27 | Stomach | Wild-type | Homo sapiens | M-NSG |
|
|||
| hHER2*ex20ins-IRES-Luc-2A-EGFP | Breast | Primary | Mus musculus |
|
||||
| HL-60 | Leukemia | Wild-type | Homo sapiens | M-NSG |
|
|||
| HL-60-Luc | Leukemia | Reporter-labeled | Homo sapiens | M-NSG |
|
|||
|
|
||||||||
